Advertisement

Topics

TriplePoint Venture Growth BDC Corp. Company Profile

13:04 EDT 19th July 2018 | BioPortfolio

The Company serves as the primary financing source for the venture growth stage business segment of TriplePoint Capital LLC, the leading global provider of financing across all stages of development to technology, life sciences and other high growth companies backed by a select group of venture capital firms. The Company’s investment objective is to maximize its total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by primarily lending with warrants to venture growth stage companies. The Company is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. More information is available at http://www.tpvg.com.


News Articles [518 Associated News Articles listed on BioPortfolio]

GTX Corp Announces Strategic Plan to Up-List to the OTCQB Venture Exchange

LOS ANGELES, June 25, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technolog...

pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc.

Acquisition and additional funding significantly accelerate the company’stransformation to a specialty biopharmaceutical company with the potential tocommercialize two ophthalmic products in 1H 2...

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

Pfizer To Expand Venture Investing With $600 Mln Commitment To Pfizer Venture

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said Wednesday that it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the company's venture ...

TriplePoint Venture Growth BDC Corp. Announces Fourth Quarter and Fiscal Year 2017 Financial Results

Record Fundings of $236.8 Million and Record Net Investment Income of $1.61 Per Share in 2017 Declares First Quarter 2018 Distribution of $0.36 per Share Tripl...

Pfizer expands venture arm with $600m cash boost

Pharma giant Pfizer is injecting $600 million into its venture investment arm in a bid to ramp up its involvement in biotechnology and other emerging growth companies. The company announced that one-...

Pfizer unveils $600m investment in venture capital arm

Pfizer is planning to invest $600 million in biotechnology and other emerging growth companies through its venture investment group.

Prior authorization automation business closes $10.5M Series A round with plans to double staff

BIP Capital, an Atlanta-based venture firm targeting growth-stage companies, led the funding round, which also included NCT Ventures and Dan Gilbert-backed Detroit Venture Partners.

PubMed Articles [1557 Associated PubMed Articles listed on BioPortfolio]

Growth and growth hormone: recent papers on efficacy and adverse effects of growth hormone and World Health Organisation growth standards.

Catch-Up Growth, Rapid Weight Growth, and Continuous Growth from Birth to 6 Years of Age in Very-Preterm-Born Children.

Breastfeeding promotes healthy growth in very-preterm-born infants (VPI), but extra nutritional supply is needed to ensure catch-up growth and brain development.

Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.

Reduced growth and osteopenia are common in individuals with cystic fibrosis (CF). Additionally, improved weight and height are associated with better lung function and overall health in the disease. ...

In Preterm Infants, Length Growth below Expected Growth during Hospital Stay Predicts Poor Neurodevelopment at 2 Years.

In preterm infants, neonatal weight growth is associated with neurodevelopmental outcome but is a poor indicator of growth quality.

Interactions between the growth hormone and cytokines - A review.

Numerous reports on the interactions between the immune and endocrine systems, especially growth hormone axis, can be found in the literature. Growth hormone acts mainly indirectly through insulin-lik...

Clinical Trials [3019 Associated Clinical Trials listed on BioPortfolio]

Quest Sound Recover (SR2) vs. Venture SR2

Goal of this study is to determine the benefit of an improved feature on a new hearing aid platform. To investigate the improvements of this feature is compared on a new and older hearing...

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

To estimate the evolution of height and growth rate over 5 years of growth hormone (GH) treatment To estimate the prognostic factors of growth rate with GH treatment To confirm the good cl...

Effects of Short-term Growth Hormone in HIV-infected Patients

The purpose of this study is to examine the short-term effects of two different doses of growth hormone on the brain's secretion of growth hormone and the body's glucose metabolism. We hy...

Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency

This study is intended to determine whether twice daily weight based dosing with recombinant human insulin-like growth factor (rhIGF-1) will safely and effectively increase the growth of p...

Companies [1648 Associated Companies listed on BioPortfolio]

TriplePoint Venture Growth BDC Corp.

The Company serves as the primary financing source for the venture growth stage business segment of TriplePoint Capital LLC, the leading global provider of financing across all...

Connecticut Venture Group

The Connecticut Venture Group’s mission is to stimulate economic growth by encouraging investment in high-growth companies. For more information, visit www.cvg.org.

Hercules Capital, Inc.

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-gr...

North Bridge Growth Equity

North Bridge Growth Equity, a leading mid-stage venture capital equity firm focused on emerging high-growth technology companies since 2007, is affiliated with North Bridge Ventur...

Florida Venture Forum

The Florida Venture Forum is Florida’s largest and most prestigious statewide support group for venture capitalists and entrepreneurs, helping emerging growth companies come ...

More Information about "TriplePoint Venture Growth BDC Corp." on BioPortfolio

We have published hundreds of TriplePoint Venture Growth BDC Corp. news stories on BioPortfolio along with dozens of TriplePoint Venture Growth BDC Corp. Clinical Trials and PubMed Articles about TriplePoint Venture Growth BDC Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TriplePoint Venture Growth BDC Corp. Companies in our database. You can also find out about relevant TriplePoint Venture Growth BDC Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record